HNRNPK and acute myeloid leukemia: In this regard, it has been reported that hnRNP K regulates the activation of transcription and translation of c‐Myc [38, 39], which is directly involved in cell proliferation and cell cycle progression [40], and it is a potential therapeutic target in AML via apoptosis induction [41].